X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Dr. Reddys Fact Sheet, Dr. Reddys Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Reddys Fact Sheet   (REDY)

Here is the latest financial fact sheet of Dr. Reddys. For more details, see the Dr. Reddys quarterly results and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.

DR. REDDYS LAB Price History

Price Rs 2,750.0
Mkt Cap Rs m 455,703
Vol '000 18.5
P/E X 26.1
P/CF X 22.9
EPS (TTM) Rs 105.4
% ch % 0.1
No. of shares m 165.71
% ch week % 3.6
% ch 1-mth % 9.0
% ch 12-mth % 27.5
52 week H/L Rs 2,875.0/1,888.0
(As on Mar 22, 2019 03:33:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DR. REDDYS LAB Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
DR. REDDYS LAB EQUITY SHARE DATA
High Rs2,9403,6624,3833,3972,788 
Low Rs1,7662,2502,7502,5601,902 
Sales per share (Unadj.) Rs788.6881.8912.5856.5860.8 
Earnings per share (Unadj.) Rs115.4137.1124.978.057.1 
Diluted earnings per shareRs118.5141.0128.678.057.1 
Cash flow per share (Unadj.) Rs153.5181.7179.9139.9122.0 
Dividends per share (Unadj.) Rs18.0020.0020.0020.0020.00 
Adj. dividends per shareRs18.4820.5620.5920.0020.02 
Dividend yield (eoy) %0.80.70.60.70.9 
Book value per share (Unadj.) Rs462.4635.8736.8739.8757.7 
Adj. book value per shareRs474.6653.8758.5740.0758.7 
Shares outstanding (eoy) m170.11170.38170.61165.74165.91 
Bonus/Rights/Conversions  ESOPESOPESOPBBESOP 
Price / Sales ratio x3.03.43.93.52.7 
Avg P/E ratio x20.421.628.638.241.1 
P/CF ratio (eoy) x15.316.319.821.319.2 
Price / Book Value ratio x5.14.64.84.03.1 
Dividend payout %15.614.616.025.735.0 
Avg Mkt Cap Rs m400,277503,643608,481493,632389,034 
No. of employees `00019.019.921.722.723.5 
Total wages/salary Rs m24,75429,44631,17431,06832,149 
Avg. sales/employee Rs Th7,060.77,565.77,184.66,259.06,070.8 
Avg. wages/employee Rs Th1,302.81,482.91,438.61,369.81,366.6 
Avg. net profit/employee Rs Th1,033.31,176.6983.2569.7402.5 
DR. REDDYS LAB INCOME DATA
Net Sales Rs m134,153150,233155,683141,961142,810 
Other income Rs m1,6972,7412,9501,7151,552 
Total revenues Rs m135,850152,974158,633143,676144,362 
Gross profit Rs m32,50834,93635,85324,72223,512 
Depreciation Rs m6,4757,5999,38910,26610,772 
Interest Rs m1,2671,082826634788 
Profit before tax Rs m26,46328,99628,58815,53713,504 
Minority Interest Rs m00000 
Prior Period Items Rs m00229349344 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m6,8315,6327,5112,9654,380 
Profit after tax Rs m19,63223,36421,30612,9219,468 
Gross profit margin %24.223.323.017.416.5 
Effective tax rate %25.819.426.319.132.4 
Net profit margin %14.615.613.79.16.6 
DR. REDDYS LAB BALANCE SHEET DATA
Current assets Rs m103,257118,096117,94096,837104,984 
Current liabilities Rs m57,90463,73463,47184,19968,938 
Net working cap to sales %33.836.235.08.925.2 
Current ratio x1.81.91.91.21.5 
Inventory Days Days6662607374 
Debtors Days Days90999798104 
Net fixed assets Rs m52,79659,06573,352102,552104,385 
Share capital Rs m851852853829830 
"Free" reserves Rs m72,946107,482124,845121,792124,886 
Net worth Rs m78,652108,334125,698122,621125,716 
Long term debt Rs m20,75514,30710,6855,44925,089 
Total assets Rs m160,296190,650203,841218,165225,443 
Interest coverage x21.927.835.625.518.1 
Debt to equity ratio x0.30.10.100.2 
Sales to assets ratio x0.80.80.80.70.6 
Return on assets %13.012.810.96.24.5 
Return on equity %25.021.617.010.57.5 
Return on capital %27.924.521.712.99.7 
Exports to sales %55.249.446.654.60 
Imports to sales %8.99.09.09.40 
Exports (fob) Rs m74,05974,14672,61877,5200 
Imports (cif) Rs m11,95913,48514,05013,2740 
Fx inflow Rs m76,00774,87075,40581,67072,623 
Fx outflow Rs m24,60726,00827,11526,35518,916 
Net fx Rs m51,40048,86248,29055,31553,707 
DR. REDDYS LAB CASH FLOW
From Operations Rs m 19,697 25,235 32,626 21,444 18,030 
From Investments Rs m -16,941 -22,647 -20,394 -18,404 -14,883 
From Financial Activity Rs m -242 -4,332 -17,001 -3,692 -4,440 
Net Cashflow Rs m 2,514 -1,744 -474 -1,144 -1,236 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 25.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 5.4%
FIIs 35.3%
ADR/GDR 18.5%
Free float 15.3%
Shareholders 75,885
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034
E-MAIL spoddar@drreddys.com WEB www.drreddys.com
TELEPHONE (040) 4900 2222 FAX (040) 4900 2999
SECTOR PHARMACEUTICALS GROUP Dr. Reddy's Group
TR AGENT Bigshare Services Ltd., G-10, Left wing, Amrutha Ville, Hyderabad - 82
AUDITOR B. S. R & Co.
CHM: G. V. Prasad COMP SEC: Sandeep Poddar YEAR OF INC: 1984 BSE CODE: 500124 FV (Rs): 5 DIV YIELD (%): 0.7

More Pharmaceuticals Company Fact Sheets:   ELDER PHARMA  CADILA HEALTHCARE  WYETH LTD  GLENMARK PHARMA  BIOCON   

Compare DR. REDDYS LAB With:   ELDER PHARMA  CADILA HEALTHCARE  WYETH LTD  GLENMARK PHARMA  BIOCON   

Compare DR. REDDYS LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Lower; HCL Technologies & Reliance Industries Top Losers(12:30 pm)

Share markets in India are presently trading on a negative note. Sectoral indices are trading mixed with stocks in the energy sector, IT sector.

Views on news

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB - TEVA PHARMA COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS